Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT06357754
- Status
- Recruiting
Conditions
- Chronic Lymphocytic Leukaemia
- Multiple Myeloma
- Non-Hodgkin Lymphoma
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Idecabtagene vicleucel — BIOLOGICALAs per product label
- Lisocabtagene maraleucel — BIOLOGICALAs per product label
Study Details
The purpose of this transgene assay testing service is to evaluate tumor samples for transgene levels in patients who received a commercially available Bristol-Myers Squibb manufactured gene modified cellular therapy and have reported a qualifying second malignancy.
Key Dates
- Start date
- Oct 6, 2023
- Status verified
- Jan 2026
- Primary completion
- Oct 6, 2038
- Completion
- Oct 6, 2038
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Participants treated with idecabtagene vicleucel
- Arm: Participants treated with lisocabtagene maraleucel
Primary Outcome Measure
Participant in situ hybridization (ISH) or droplet-based digital Polymerase chain reaction (ddPCR) transgene testing results [ Time Frame: Baseline ]
Central Contacts
- BMS Study Connect Contact Center www.BMSStudyConnect.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Local Institution - 0016 | Portland | Oregon | 97239-3098 | Site 0016 |
| Ut Southwestern | Dallas | Texas | 75235 | Larry Anderson, Site 0008 214-648-5906 |
| Huntsman Cancer Institute at the University of Utah | Salt Lake City | Utah | 84112 | Lauren Lee, Site 0010 |
| Local Institution - 0004 | Madison | Wisconsin | 53792 | - |
Find similar trials in Portland, OR
By condition
By specialty
Related Studies
- Collection of Tissue Samples for Cancer ResearchRecruiting · National Cancer Institute (NCI) · Sacramento, California
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)Recruiting · Center for International Blood and Marrow Transplant Research · Birmingham, Alabama
- Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)PHASE1 · Recruiting · Baylor College of Medicine · Houston, Texas
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado